The Riverside closure underscores a hard truth: resilience is not free. Maintaining onshore or near-shore manufacturing ...

Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.

In anticipation of the next major global pandemic, it is paramount that the global response to the Covid-19 pandemic is assessed. Especially now, as we see more diseases emerging in both unexpected ...

There are different kinds of vaccines, and each requires different processes to move from the laboratory to your physician's ...

If the government wants to expand U.S. manufacturing, it must invest in the already booming vaccine industry. Vaccines Are Already ‘Made in America’ The push to bring manufacturing back to America ...

With potential passage of the BIOSECURE Act looming and WuXi Biologics seeing its share price and profits decline, the Chinese biopharma contract manufacturing giant is responding with a sizable ...

SEATTLE--(BUSINESS WIRE)--Access to Advanced Health Institute (AAHI), a global leader in translating high-impact science into scalable, field-ready vaccine solutions, today announced an exciting new ...

Following a string of vaccine expansion projects last year, Sanofi is eyeing a new path to potentially grow the reach of its immunizations, this time in Vietnam. Sanofi and the Vietnam Vaccine Company ...

Automation and artificial intelligence (AI) will be key to a new effort to manufacture millions of RNA vaccines in Africa, according to Cairo, Egypt-headquartered drug firm Eva Pharma. Eva Pharma made ...

JOHANNESBURG (Reuters) -South African biopharmaceutical firm Biovac on Thursday opened a state-of-the-art product development laboratory in Cape Town, backed by the Gates Foundation, to help the ...